ERYTECH PHARMA - SPON ADR (ERYP) Stock Price, Quote, News and Overview

What is the stock price of ERYTECH PHARMA - SPON ADR today?

The current stock price of ERYP is 0.78 USD.

What is the ticker symbol for ERYTECH PHARMA - SPON ADR stock?

The exchange symbol of ERYTECH PHARMA - SPON ADR is ERYP and it is listed on the Nasdaq exchange.

On which exchange is ERYP stock listed?

ERYP stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for ERYTECH PHARMA - SPON ADR stock?

9 analysts have analysed ERYP and the average price target is 3.94 USD. This implies a price increase of 405.11% is expected in the next year compared to the current price of 0.78. Check the ERYTECH PHARMA - SPON ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is ERYTECH PHARMA - SPON ADR worth?

ERYTECH PHARMA - SPON ADR (ERYP) has a market capitalization of 26.61M USD. This makes ERYP a Nano Cap stock.

How many employees does ERYTECH PHARMA - SPON ADR have?

ERYTECH PHARMA - SPON ADR (ERYP) currently has 49 employees.

What are the support and resistance levels for ERYTECH PHARMA - SPON ADR (ERYP) stock?

ERYTECH PHARMA - SPON ADR (ERYP) has a support level at 0.7 and a resistance level at 0.81. Check the full technical report for a detailed analysis of ERYP support and resistance levels.

Is ERYTECH PHARMA - SPON ADR (ERYP) expected to grow?

The Revenue of ERYTECH PHARMA - SPON ADR (ERYP) is expected to grow by 16.44% in the next year. Check the estimates tab for more information on the ERYP EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy ERYTECH PHARMA - SPON ADR (ERYP) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of ERYP, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of ERYP, evaluating the profitability, health, valuation and growth aspects
• ERYTECH PHARMA - SPON ADR (ERYP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• ERYTECH PHARMA - SPON ADR (ERYP) Sales and EPS estimates to see what analysts future expectations are.
• ERYTECH PHARMA - SPON ADR (ERYP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• ERYTECH PHARMA - SPON ADR (ERYP) Insider and Institutional Ownership to learn about the owners and their transactions.
• ERYTECH PHARMA - SPON ADR (ERYP) Stock Chart to make your own analysis
• ERYTECH PHARMA - SPON ADR (ERYP) Latest news and press-releases to stay up to date.

Does ERYTECH PHARMA - SPON ADR (ERYP) stock pay dividends?

ERYP does not pay a dividend.

When does ERYTECH PHARMA - SPON ADR (ERYP) report earnings?

ERYTECH PHARMA - SPON ADR (ERYP) will report earnings on 2023-09-11, after the market close.

What is the Price/Earnings (PE) ratio of ERYTECH PHARMA - SPON ADR (ERYP)?

ERYTECH PHARMA - SPON ADR (ERYP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.55).

ChartMill assigns a fundamental rating of 3 / 10 to ERYP. While ERYP seems to be doing ok healthwise, there are quite some concerns on its profitability.

Over the last trailing twelve months ERYP reported a non-GAAP Earnings per Share(EPS) of -0.55. The EPS increased by 99.68% compared to the year before.

ChartMill assigns a Buy % Consensus number of 42% to ERYP. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 22.35% and a revenue growth 16.44% for ERYP